Dr Elliott Fegelman, from Johnson & Johnson, discusses the role of research for the future of bariatric surgery and what lies ahead for Project Game Changer.
Dr Elliott Fegelman, from Johnson & Johnson, discusses the role of research for the future of bariatric surgery and what lies ahead for Project Game Changer.